target directory

adenosine clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT00781404
Source recordAI-normalized

Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.

OBJECTIVE: to evaluate the safety and efficacy of a brief intracoronary infusion of ADO applied at the time of reperfusion to limit infarct size and LV remodelling in patients with ACSST submitted to primary ACTP. DESIGN: Multicentric, prospective, randomised, parallel, placebo-controlled double-blind study. PATIENTS: 200 patients older than 18 with ACSST and without prior myocardial infarction receiving primary PTCA within 6 hours after symptom onset.

AI analysis

Indication: Acute Myocardial Infarction

Modality: small molecule

Target: Adenosine

Sponsor: David Garcia-Dorado

Source URL: ClinicalTrials.gov

Source updated: Feb 18, 2013

Ingested: Jun 18, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: Adenosine

View original source fields

Condition raw: Acute Myocardial Infarction

Condition normalized: Acute Myocardial Infarction

Modality raw: small molecule

Modality normalized: small molecule

Target raw: Adenosine

Target normalized: Adenosine

Open report